Medical Devices
-
OIG report finds Medicare overpaying for CGMs and supplies
The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five years, the government watchdog said.
By Elise Reuter • Nov. 26, 2025 -
Lawmakers propose Medicare reimbursement pathway for AI devices
AdvaMed supports the legislation, which is intended to ensure AI-enabled devices receive an accurate CMS payment code.
By Nick Paul Taylor • Nov. 26, 2025 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
CMS covers cardiac ablation in ambulatory surgery centers
Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.
By Susan Kelly • Nov. 26, 2025 -
Medtronic taps Jim Peichel as CTO
Peichel, who has worked at Medtronic for more than 25 years, succeeds Ken Washington, who retired earlier this month.
By Elise Reuter • Nov. 25, 2025 -
Ceribell wins FDA clearance for seizure-detection algorithm in neonates
By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 million market.
By Nick Paul Taylor • Nov. 25, 2025 -
Abbott issues correction for millions of glucose sensors
The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.
By Elise Reuter • Nov. 24, 2025 -
Okami raises $45M to commercialize vascular embolization devices
The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.
By Nick Paul Taylor • Nov. 24, 2025 -
Insulet unveils plans for new diabetes devices
The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 diabetes in 2028.
By Elise Reuter • Nov. 24, 2025 -
Q&A
Shockwave’s Nick West on shaking up treatment for blocked arteries
The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the pipeline in a conversation with MedTech Dive.
By Susan Kelly • Nov. 21, 2025 -
Solventum inks $725M Acera takeover
The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.
By Nick Paul Taylor • Nov. 21, 2025 -
Abbott to acquire Exact Sciences for about $21B
The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.
By Elise Reuter , Susan Kelly • Updated Nov. 20, 2025 -
Philips, Edwards team on AI-based guide for mitral valve repair
Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device during transcatheter heart procedures.
By Susan Kelly • Nov. 19, 2025 -
Distalmotion raises $150M to commercialize surgical robot
By targeting ambulatory surgery centers, the company is gearing up to compete with Intuitive Surgical for an emerging opportunity.
By Nick Paul Taylor • Nov. 19, 2025 -
Boston Scientific, Siemens Healthineers partner on cardiac catheter
Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston Scientific’s Watchman device.
By Susan Kelly • Nov. 17, 2025 -
Jury orders Apple to pay Masimo $634M in patent fight
Apple said it plans to appeal the verdict, which could delay Masimo’s collection of the damages by as much as two years, one analyst said.
By Susan Kelly • Nov. 17, 2025 -
Q&A
Resmed CEO Mick Farrell on new technologies, tariffs and AI
The incoming AdvaMed chair talked about updates to Resmed’s products and how the company is handling competitive dynamics and tariffs.
By Elise Reuter • Updated Nov. 18, 2025 -
Zimmer wins FDA clearance for updated knee robot
Competing with companies including Stryker and J&J, Zimmer has moved to strengthen its position by developing an updated robot.
By Nick Paul Taylor • Nov. 17, 2025 -
Vicarious says it will outsource some robot development functions
The initiative is part of a restructuring to preserve cash while the company completes the design of the robotic surgery system it plans to commercialize.
By Susan Kelly • Nov. 14, 2025 -
Cornerstone raises $200M to commercialize surgical robot
The financing comes 11 months after Cornerstone raised $70 million to support the launch of its device in China.
By Nick Paul Taylor • Nov. 13, 2025 -
Siemens to reduce stake in Siemens Healthineers
Siemens Healthineers CEO Bernd Montag said the decision is a “natural next step in our journey to becoming a fully independent company.”
By Susan Kelly • Nov. 13, 2025 -
Stereotaxis nets FDA clearance for redesigned surgical robot
The company also posted weaker third-quarter results, but CEO David Fischel said orders for the new GenesisX system, when fully launched, would outpace the rate for an older model.
By Susan Kelly • Nov. 12, 2025 -
Medtech VC funding slows in Q3: PitchBook
The lowest level of quarterly VC funding since 2023 has tempered expectations that the sector will achieve its best year since 2021.
By Nick Paul Taylor • Nov. 12, 2025 -
Laborie inks $465M deal to buy post-childbirth device from Organon
Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.
By Nick Paul Taylor • Nov. 10, 2025 -
MMI tackles Alzheimer’s; SS Innovations advances telesurgery
MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass surgery with a new console, and Procept BioRobotics’ Q3 revenue rose 43%.
By Susan Kelly • Nov. 10, 2025 -
Retrieved from Olympus on February 03, 2025
Olympus to cut 2,000 jobs in endoscopy reorganization
The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.
By Susan Kelly • Nov. 7, 2025